Nexavar Significantly Improved Overall Survival in Phase 3 Asia … - CNNMoney.com
Nexavar Significantly Improved Overall Survival in Phase 3 Asia …CNNMoney.com - Aug 26, 2007(5) This double-blind, randomized, placebo-controlled Phase 3 trial was designed to evaluate Nexavar in patients with advanced HCC, or primary liver cancer, …
Read full story